Immunai

1 follower


Immunai is comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes.

Industries

Headquarters

Stage

Employees

Links

Noam Solomon
Co-Founder & CEO

Noam Solomon

Collapse
Luis Voloch
Co-Founder & CTO
Jacques Banchereau
Chief Science Officer
Sen Zhang
VP, Product Management
Ethan Grant
VP, Therapeutic Discovery
Evan Zisholtz
VP, Corporate Development
Tal Weiss
Financial Controller
Shlomit Melamud
HR Coordinator & Talent Acquisition Specialist
Elisha Nathan
VP Strategic Alliances